Personal tools

MCL coexpression mm9:1492: Difference between revisions

From FANTOM5_SSTAR

Jump to: navigation, search
No edit summary
No edit summary
Line 6: Line 6:
|ontology_enrichment_disease=
|ontology_enrichment_disease=
|ontology_enrichment_uberon=UBERON:0000992!4.90e-53!3;UBERON:0004176!3.95e-26!17;UBERON:0009196!3.95e-26!17;UBERON:0009117!3.95e-26!17;UBERON:0000991!1.01e-24!18;UBERON:0005564!1.01e-24!18;UBERON:0003134!1.53e-20!8;UBERON:0003133!9.72e-19!24;UBERON:0000474!2.30e-18!9;UBERON:0005156!2.36e-17!26;UBERON:0000990!2.36e-17!26;UBERON:0003100!3.43e-15!11;UBERON:0002323!2.12e-12!37;UBERON:0004458!2.12e-12!37;UBERON:0003886!4.33e-12!38;UBERON:0002553!8.52e-12!39;UBERON:0001343!6.19e-10!2;UBERON:0004910!6.19e-10!2;UBERON:0004909!6.19e-10!2;UBERON:0005154!6.19e-10!2;UBERON:0005295!6.19e-10!2;UBERON:0005297!6.19e-10!2;UBERON:0005294!6.19e-10!2;UBERON:0010141!6.19e-10!2;UBERON:0005891!6.19e-10!2;UBERON:0000464!2.96e-08!57;UBERON:0001301!4.77e-07!3;UBERON:0006555!4.77e-07!3;UBERON:0005103!4.77e-07!3;UBERON:0000083!4.77e-07!3;UBERON:0009201!4.77e-07!3;UBERON:0004819!4.77e-07!3;UBERON:0006553!4.77e-07!3;UBERON:0003074!4.77e-07!3;UBERON:0004871!4.77e-07!3;UBERON:0003060!4.77e-07!3
|ontology_enrichment_uberon=UBERON:0000992!4.90e-53!3;UBERON:0004176!3.95e-26!17;UBERON:0009196!3.95e-26!17;UBERON:0009117!3.95e-26!17;UBERON:0000991!1.01e-24!18;UBERON:0005564!1.01e-24!18;UBERON:0003134!1.53e-20!8;UBERON:0003133!9.72e-19!24;UBERON:0000474!2.30e-18!9;UBERON:0005156!2.36e-17!26;UBERON:0000990!2.36e-17!26;UBERON:0003100!3.43e-15!11;UBERON:0002323!2.12e-12!37;UBERON:0004458!2.12e-12!37;UBERON:0003886!4.33e-12!38;UBERON:0002553!8.52e-12!39;UBERON:0001343!6.19e-10!2;UBERON:0004910!6.19e-10!2;UBERON:0004909!6.19e-10!2;UBERON:0005154!6.19e-10!2;UBERON:0005295!6.19e-10!2;UBERON:0005297!6.19e-10!2;UBERON:0005294!6.19e-10!2;UBERON:0010141!6.19e-10!2;UBERON:0005891!6.19e-10!2;UBERON:0000464!2.96e-08!57;UBERON:0001301!4.77e-07!3;UBERON:0006555!4.77e-07!3;UBERON:0005103!4.77e-07!3;UBERON:0000083!4.77e-07!3;UBERON:0009201!4.77e-07!3;UBERON:0004819!4.77e-07!3;UBERON:0006553!4.77e-07!3;UBERON:0003074!4.77e-07!3;UBERON:0004871!4.77e-07!3;UBERON:0003060!4.77e-07!3
|tfbs_overrepresentation_for_novel_motifs=0.557864,0.293744,0.529553,0.603273,0.406364,0.618805,0.715644,0.812379,0.836099,0.115752,0.668936,0.702872,0.300533,0.728641,0.424775,0,0.930881,1.02841,0.283802,1.0421,0.489529,0.145201,0.727684,0.404661,0.537749,0.757752,0.754069,0.641282,0.456327,0.645258,0.626183,1.03545,0.395107,0.704734,0.425309,0.454919,0.384813,0.699032,0.360612,0.328675,1.03785,0.631725,0.830062,0.426986,0.227872,0.591277,0.847828,0.658142,0.370501,0.459555,0.912738,0.786094,0.220111,1.18062,1.19842,0.73621,0.469329,0.689304,0.731291,0.734051,1.01481,0.796017,0.323911,0.901018,0.747985,0.943088,1.33705,1.68977,1.00999,1.54147,0.509047,0.30684,0.152094,1.23259,0.257421,0.245132,0.253065,0.835925,0.997094,0.494135,0.308173,0.948899,0.794502,0.293164,1.1148,0.0793594,0.0882907,0.227755,0.852952,1.85284,1.40768,1.11989,1.04863,0.412897,0.356133,0.3366,0.297538,1.05152,0.848095,0.20438,0.384901,1.03517,1.16282,0.913356,0.91226,0.631253,0.97421,0.653843,0.499439,0.491483,0.550229,1.16464,0.495367,0.674448,1.41481,1.03353,0.0998646,0.607321,0.932233,0.380707,1.23809,0.879184,0.759676,0.834976,1.46955,1.00091,0.724289,1.04166,1.33551,0.416189,1.14546,0.595426,1.3055,0.750642,1.43666,0.143464,0.566955,0.633235,1.3869,2.2222,1.82084,1.34183,0.772375,1.04623,0.905521,0.632211,0.851091,2.18247,1.39694,0.408309,0.651755,0.133815,1.18223,0.343194,0.749664,1.26545,0.787153,0.438007,3.43799,0.566652,1.39653,1.11392,1.00137,0.547782,0.90208,0.741834,0.383572,1.67247,0.0513167
}}
}}

Revision as of 19:59, 26 November 2012


Phase1 CAGE Peaks

 Short description
Mm9::chr10:107980160..107980166,+p@chr10:107980160..107980166
+
Mm9::chr11:103799525..103799531,-p5@Nsf
Mm9::chr6:95283986..95283988,-p1@AY512915
Mm9::chr7:24170907..24170914,+p1@Nlrp5
Mm9::chrX:140752342..140752344,+p6@Alg13


Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data


GO IDGO nameFDR corrected p-value
GO:0004577N-acetylglucosaminyldiphosphodolichol N-acetylglucosaminyltransferase activity0.0124910973538596
GO:0030259lipid glycosylation0.024978088645562
GO:0019905syntaxin binding0.0499233377932877
GO:0000149SNARE binding0.0499233377932877



Relative expression of the co-expression cluster over median <br>Analyst:





Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br><br>uberon_data<br><br>


Uber Anatomy
Ontology termp-valuen
female gonad4.90e-533
external genitalia3.95e-2617
indifferent external genitalia3.95e-2617
indifferent gonad3.95e-2617
gonad1.01e-2418
gonad primordium1.01e-2418
female reproductive organ1.53e-208
reproductive organ9.72e-1924
female reproductive system2.30e-189
reproductive structure2.36e-1726
reproductive system2.36e-1726
female organism3.43e-1511
body cavity2.12e-1237
body cavity or lining2.12e-1237
body cavity precursor4.33e-1238
anatomical cavity8.52e-1239
seminiferous tubule of testis6.19e-102
epithelium of male gonad6.19e-102
epithelium of gonad6.19e-102
epithelial cord6.19e-102
sex cord6.19e-102
testis sex cord6.19e-102
genital ridge6.19e-102
primitive sex cord of indifferent gonad6.19e-102
coelomic epithelium6.19e-102
anatomical space2.96e-0857
epididymis4.77e-073
excretory tube4.77e-073
mesonephric epithelium4.77e-073
mesonephric tubule4.77e-073
nephric duct4.77e-073
kidney epithelium4.77e-073
renal duct4.77e-073
mesonephric duct4.77e-073
somatic layer of lateral plate mesoderm4.77e-073
pronephric duct4.77e-073


TFBS overrepresentation<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data


Novel motifs




JASPAR motifs


Motifs-log10(p-value)

{{{tfbs_overrepresentation_jaspar}}}